Surgery Partners (NASDAQ:SGRY) vs. Oncology Institute (NASDAQ:TOI) Head-To-Head Analysis

Oncology Institute (NASDAQ:TOI) and Surgery Partners (NASDAQ:SGRY) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Profitability

This table compares Oncology Institute and Surgery Partners’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-13.21%	-1,527.21%	-35.30%
Surgery Partners	-5.21%	2.41%	0.96%

Analyst Recommendations

This is a breakdown of recent recommendations for Oncology Institute and Surgery Partners, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	1	0	3	1	2.80
Surgery Partners	1	2	7	0	2.60

Oncology Institute presently has a consensus target price of $6.50, indicating a potential upside of 68.18%. Surgery Partners has a consensus target price of $27.11, indicating a potential upside of 66.84%. Given Oncology Institute’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Oncology Institute is more favorable than Surgery Partners.

Earnings & Valuation

This table compares Oncology Institute and Surgery Partners”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$393.41 million	0.97	-$64.66 million	($0.64)	-6.04
Surgery Partners	$3.29 billion	0.64	-$168.10 million	($1.36)	-11.95

Oncology Institute has higher earnings, but lower revenue than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

36.9% of Oncology Institute shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by company insiders. Comparatively, 2.7% of Surgery Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk and Volatility

Oncology Institute has a beta of 0.15, indicating that its stock price is 85% less volatile than the S&P 500. Comparatively, Surgery Partners has a beta of 1.91, indicating that its stock price is 91% more volatile than the S&P 500.

Summary

Oncology Institute beats Surgery Partners on 9 of the 15 factors compared between the two stocks.

About Oncology Institute

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

About Surgery Partners

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.